Michele Baptista

Senior Director of Business Development

Michele Baptista brings extensive industry knowledge to Sabai, having worked within the ethics and regulatory review sector for more than 30 years. During that time Michele co-founded Aspire IRB and held various Operational and Commercial responsibilities until Aspire was acquired by WCG in 2014. Michele remained at WCG for almost 20 years before departing for a role within the CenExel site network, prior to joining us at Sabai. Michele was among the first 100 individuals in the country to become a Certified IRB Professional, a designation she has held for 20+ years. Michele is well known to many Sabai employees, brings extensive industry knowledge and strong West Coast connections, and was also responsible for promoting Sabai services when she was at Cenexel.

Michele is based in the San Diego area. When she’s not working, Michele is an avid fan of all things Disney, riding eBikes, and the cheering on the San Diego Padres.

Back to our Team

Mission Statement

The mission of Castle IRB is to protect the rights and welfare of human participants in gene and cell therapy clinical trials while providing efficient, compliant IRB review of research. Using our portfolio of expertise, we strive to be the leading IRB partner in advancing safe, ethical and compliant gene and cell therapy clinical trials to accelerate the next evolution in advanced therapies.